搜索临床试验以:Apatinib SHR-1210(Camrelizumab)
总计289个结果
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Shanghai Chest Hospital尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Fudan UniversityShanghai Shen Kang Hospital Development Center招聘中
-
The First Affiliated Hospital of Zhengzhou University尚未招聘可切除的食管鳞状细胞癌
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.未知肝细胞癌 | 非小细胞肺癌 | 钢筋混凝土
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Sixth Affiliated Hospital, Sun Yat-sen University尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.完全的局部晚期或转移性和不可切除的 HCC美国, 西班牙, 中国, 台湾, 比利时, 大韩民国, 意大利, 香港, 俄罗斯联邦, 乌克兰, 火鸡, 波兰, 德国
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.招聘中